Rich Meyer

Rich Meyer is a pharmaceutical executive and advisor with over 25 years of experience in the industry. Rich began their career as an assistant professor at the University of California, San Francisco, before moving into the private sector with Epoch Pharmaceuticals. Rich spent seven years at Epoch, rising to the position of vice president of research and development before leaving to become an independent advisor. In this role, they have worked with InSilixa, a startup focused on developing new treatments for cancer.

Rich Meyer has a PhD in organic chemistry and medicinal chemistry from UC Santa Barbara.